Announcements Trials
Browse Landscape

Phase

Phase 2 113Phase 1 24Phase 1/2 17Phase NA 8Phase 3 6Phase 2/3 3Phase 4 2Phase EARLY_PHASE1 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2CNS 1

Conditions

Recurrence 1Glioblastoma 1Colorectal Neoplasms 1Asian Colorectal Cancer Patients 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × regorafenib × Clear all
NCT03970447 2026-05-15

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting
2,250 enrolled
CNS

Glioblastoma, Recurrence

NCT05462613 2024-12-20

REPROGRAM-02

Centre Hospitalier Universitaire de Besancon

Phase 2/3 Recruiting
446 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01189903 2014-01-28

Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer Patients

National University Hospital, Singapore

Phase 2/3 Unknown
Gastrointestinal

Asian Colorectal Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡